Abstract: Colorectal cancer (CRC) is the fourth most commonly diagnosed cancer and the second leading cause of cancer death in the United States of America. Organoids, specifically CRC organoids have emerged as a powerful preclinical model as they closely recapitulate patient-specific tumor features, including tumor morphology, genetics, and treatment response. However, most organoid culture systems […]
Eligibility & Submission Rules: Applicants may submit only one entry per person for this travel award. Submissions for multiple events are not permitted and will result in disqualification. Duplicate entries (e.g., submissions under different email addresses) will be voided. Four (4) applicants will be selected randomly per event. Terms and Conditions Apply. To apply, please […]
Learn how a streamlined xeno-free platform supports efficient organoid establishment, growth, and maintenance. Organoid technology has rapidly become a powerful platform for disease modeling, drug discovery, and translational biomedical research. However, most organoid systems still rely on highly specialized media formulations tailored to individual organoid types. There is currently no universal culture medium that supports […]
Monmouth Junction, NJ — March 4, 2026 — TheWell Bioscience, a leader in advanced xeno-free cell culture technologies, today announced the launch of RocketCell™ hMSC Xeno-Free Complete Growth Medium, a chemically defined, xeno-free medium engineered for high-performance human mesenchymal stem cell (hMSC) expansion across research, translational development, and cell therapy manufacturing workflows. As regulatory agencies […]
Learn how a standardized xeno-free platform enables a robust, multipotent MSC expansion suitable for translational application. Human mesenchymal stem cells (hMSCs) have evolved from an early cytological discovery into a cornerstone of regenerative medicine, with over 70,000 publications supporting their therapeutic potential. First described as colony-forming unit fibroblasts by Alexander Friedenstein and later defined as […]
Inside SLAS2026: Key Highlights, Connections, and Innovations SLAS2026 was an energizing week of scientific exchange, meaningful conversations, and hands-on demonstrations for the team at TheWell Bioscience. The event offered an invaluable opportunity to connect with researchers and partners, explore the evolving needs in automated 3D cell culture and organoid research, and showcase how TheWell Bioscience’s […]
Learn how an integrated, xeno-free platform with optimized matrix, medium, and reagents can accelerate your path to reproducible, clinically aligned 3D iPSC models. Induced pluripotent stem cells (iPSCs) provide a powerful foundation for disease modeling, organoid development, and cell therapy applications. However, most iPSC research is still performed in two-dimensional (2D) systems that fail to […]
A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate Monmouth Junction, NJ — February 9, 2026 — TheWell Bioscience today announced the launch of the VitroPrime™ 3D Culture and Imaging Plate, a next-generation 3D cell culture plate engineered to support organoid and advanced […]
VitroGel® enables precise modeling of breast tissue stiffness to study how anti-progestin therapy suppresses cancer cells. Breast cancer remains the leading cause of cancer-related death in women worldwide. A key risk factor in breast cancer development is partly attributed to high mammographic density, which is not only visible on mammograms but is also driven by […]
Advancing Automated 3D Cell Culture with an End-to-End Xeno-Free Platform at SLAS 2026! TheWell Bioscience will attend SLAS 2026 (Society for Laboratory Automation and Screening), the premier international conference and exhibition for laboratory automation, screening, and life sciences innovation, taking place February 9–11, 2026, at the Thomas Michael Menino Convention & Exhibition Center (MCEC) in […]
